Cavanagh D - Search Results

1

Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes.

Lusingu JP, Jensen AT, Vestergaard LS, Minja DT, Dalgaard MB, Gesase S, Mmbando BP, Kitua AY, Lemnge MM, Cavanagh D, Hviid L, Theander TG. Lusingu JP, et al. Among authors: cavanagh d. Infect Immun. 2006 May;74(5):2867-75. doi: 10.1128/IAI.74.5.2867-2875.2006. Infect Immun. 2006. PMID: 16622225 Free PMC article.

2

Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.

Cavanagh DR, Dodoo D, Hviid L, Kurtzhals JA, Theander TG, Akanmori BD, Polley S, Conway DJ, Koram K, McBride JS. Cavanagh DR, et al. Infect Immun. 2004 Nov;72(11):6492-502. doi: 10.1128/IAI.72.11.6492-6502.2004. Infect Immun. 2004. PMID: 15501780 Free PMC article.

3

Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.

Cavanagh DR, Dobaño C, Elhassan IM, Marsh K, Elhassan A, Hviid L, Khalil EA, Theander TG, Arnot DE, McBride JS. Cavanagh DR, et al. Infect Immun. 2001 Feb;69(2):1207-11. doi: 10.1128/IAI.69.2.1207-1211.2001. Infect Immun. 2001. PMID: 11160024 Free PMC article.

4

A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.

Fonjungo PN, Elhassan IM, Cavanagh DR, Theander TG, Hviid L, Roper C, Arnot DE, McBride JS. Fonjungo PN, et al. Among authors: cavanagh dr. Infect Immun. 1999 Jun;67(6):2975-85. doi: 10.1128/IAI.67.6.2975-2985.1999. Infect Immun. 1999. PMID: 10338508 Free PMC article.

5

α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes.

Stevenson L, Laursen E, Cowan GJ, Bandoh B, Barfod L, Cavanagh DR, Andersen GR, Hviid L. Stevenson L, et al. PLoS Pathog. 2015 Jul 2;11(7):e1005022. doi: 10.1371/journal.ppat.1005022. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26134405 Free PMC article.

6

A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.

Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, Hviid L, Theander TG, Arnot DE, McBride JS. Cavanagh DR, et al. J Immunol. 1998 Jul 1;161(1):347-59. J Immunol. 1998. PMID: 9647243

7

Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.

Polley SD, Tetteh KK, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, Okenu DM, Greenwood BM, McBride JS, Conway DJ. Polley SD, et al. Among authors: cavanagh dr. Infect Immun. 2003 Apr;71(4):1833-42. doi: 10.1128/IAI.71.4.1833-1842.2003. Infect Immun. 2003. PMID: 12654798 Free PMC article.

8

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K. Osier FH, et al. Among authors: cavanagh dr. Infect Immun. 2008 May;76(5):2240-8. doi: 10.1128/IAI.01585-07. Epub 2008 Mar 3. Infect Immun. 2008. PMID: 18316390 Free PMC article.

9

Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines.

Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, van der Werff N, van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CH. Faber BW, et al. Infect Immun. 2013 May;81(5):1479-90. doi: 10.1128/IAI.01267-12. Epub 2013 Feb 19. Infect Immun. 2013. PMID: 23429538 Free PMC article.

10

Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Moss DK, Remarque EJ, Faber BW, Cavanagh DR, Arnot DE, Thomas AW, Holder AA. Moss DK, et al. Infect Immun. 2012 Mar;80(3):1280-7. doi: 10.1128/IAI.05887-11. Epub 2011 Dec 27. Infect Immun. 2012. PMID: 22202121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page